I E Leppik1. Show Affiliations » 1. MINCEP Epilepsy Care, and Department of Neurology and Pharmacy, University of Minnesota, Minneapolis 55427, USA.
Abstract
Mesh： See more » AnimalsAnticonvulsants/adverse effectsAnticonvulsants/pharmacologyAnticonvulsants/therapeutic useClinical Trials as TopicDrug InteractionsEpilepsies, Partial/drug therapyEpilepsy/drug therapyFelbamateFructose/adverse effectsFructose/analogs & derivativesFructose/pharmacologyFructose/therapeutic useHumansLamotrigineNipecotic Acids/adverse effectsNipecotic Acids/pharmacologyNipecotic Acids/therapeutic usePhenylcarbamatesPropylene Glycols/adverse effectsPropylene Glycols/pharmacologyPropylene Glycols/therapeutic useTeratogensTiagabineTopiramateTriazines/adverse effectsTriazines/pharmacologyTriazines/therapeutic useVigabatringamma-Aminobutyric Acid/adverse effectsgamma-Aminobutyric Acid/analogs & derivativesgamma-Aminobutyric Acid/pharmacologygamma-Aminobutyric Acid/therapeutic use
Substances： See more » AnticonvulsantsNipecotic AcidsPhenylcarbamatesPropylene GlycolsTeratogensTriazinesTopiramateFructosegamma-Aminobutyric AcidVigabatrinLamotrigineFelbamateTiagabine
Year: 1998 PMID： 9737436 DOI： 10.1111/j.1528-1157.1998.tb05141.x
Source DB: PubMed Journal: Epilepsia ISSN： 0013-9580 Impact factor: 5.864